We are live on ! Find out more

105 hedge funds and large institutions have $65.4M invested in PAVmed in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 28

0.01% more ownership

Funds ownership: 0.06%0.07% (+0.01%)

3% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 30

2% less funds holding

Funds holding: 107105 (-2)

11% less call options, than puts

Call options by funds: $740K | Put options by funds: $833K

67% less capital invested

Capital invested by funds: $199M → $65.4M (-$133M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
105
Holders Change
-2
Holders Change %
-1.87%
% of All Funds
1.62%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
29
Increased
30
Reduced
28
Closed
30
Calls
$740K
Puts
$833K
Net Calls
-$93K
Net Calls Change
-$1.95M

PAVM Hedge Fund Activity: Q4 2021 in Review

105 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2021, worth a combined $65.4M — down 67% from $199M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of PAVM and 29 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 30 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $8.48M. The largest seller was Fidelity Investments, exiting entirely with an estimated $12.1M sold.

  • 105 institutional investors held PAVmed (PAVM) as of Q4 2021, down from 107 in Q3 2021.
  • Funds reported $65.4M of PAVmed stock for Q4 2021, down 67% quarter-over-quarter.
  • 29 funds opened new PAVmed positions in Q4 2021 and 30 closed out, a net change of -1 holder.
  • The largest PAVmed buyer in Q4 2021 was Two Sigma Investments, an estimated $8.48M added.
  • The largest PAVmed seller in Q4 2021 was Fidelity Investments, an estimated $12.1M sold.

Based on aggregated 13F filings for Q4 2021.